Efficacy Study of Radiotherapy Alone Versus CCRT With Temozolomide in Grade III Gliomas Without 1p/19q Codeletion
NCT01534845
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Anaplastic Glioma of Brain
Loss of Chromosomes 1p/19q
Interventions
DRUG:
Temozolomide (Temodal)
Sponsor
Jong Hoon Kim